68
DAFTAR PUSTAKA
ASHP, 1997. American Society of Health - System Pharmacist (ASHP) Guidelines on Pharmacist - Conducted Patient Education and Counseling.
Am. J. Health - Syst. Pharm., 54: 431–434.
Anggraini, D.T., 2015. 'Evaluasi Pengaruh Kesesuaia Terapi Hipertensi Dengan Guideline JNC 7 Terhadap Tercapainya Target Tekanan Darah Pasien di RS Panti Waluyo Surakarta Periode Januari-Desember 2013'. Thesis.
Uniersitas Gadjah Mada Yogyakarta.
Azwar, S., 2003. Reabilitas Dan Validitas. Pustaka Pelajar, Yogyakarta.
Barry, L.C. 2004, Implementing the New Guidelines for Hypertension : JNC VII, ADA, WHA - ISH, J Management Care Pharm., 10 (5) : 18-25.
British National Formulary, 2003. British National Formulary 46th Edition, 46th ed. British Medical Association, London.
Brown, N.J. dan Vaughan, D.E., 1998. Angiotensin-converting enzyme inhibitors.
Circulation, 97: 1411–1420.
Bustan MN. 2000. Epidemiologi penyakit tidak menular. Jakarta: Rineka Cipta.
CDC, 2010. Healthy People 2010. Centers for Disease Control and Prevention National Institutes of Health, 12-14.
CDC, 2014. Know The Facts About High Blood Pressure. National Center for Chronic Disease Prevention and Health Promotion, Division for Hearth Disease and Stroke Prevention, Atlanta.
Chang, C. dan Green, S., 2011. Hypertension Management in the Dominican Republic: Factors Affecting Medication Adherence. Health Horizons International Summer Interns, 2 : 8-12.
Chobanian, A.V., Bakris, G.L., William C., C., Lee A., G., dan Joseph L., I.J., 2003. Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health, 42 : 1206.
Curb, J.D., Pressel, S.L., Cutler, J.A., Savage, P.J., Applegate, W.B., Black, H., dkk., 1996. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA, 276: 1886–1892.
Chusna, N. 2014. 'Evaluasi Pengaruh Kepatuhan Dan pola Pengobatan Terhadap Hasil Terapi Pasien Hipertensi di Poliklinik Penyakit Dalam RSUD DR.
Doris Sylvanus Palangkaraya'. Thesis. Universitas Gadjah Mada Yogyakarta.
Depkes, 2006. Pharmaceutical Care Untuk Penyakit Hipertensi. Departemen Kesehatan RI, Jakarta.
Depkes, 2007. Pharmaceutical Care Untuk Penyakit Hipertensi. Departemen Kesehatan RI, Jakarta.
Depkes, L., 2013. Riset Kesehatan Dasar 2013. Departemen Kesehatan RI, Jakarta.
DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B., dan Posey, L.M., 2008.Pharmacotherapy: A Pathophysiologic Approach, 7 edition.
ed.McGraw-Hill Medical, New York.
Fajar, N. 2009, „Analisis Faktor Sosial Budaya dalam Keluarga yang Mempengaruhi Pengobatan Dini dan Keteraturan Berobat Pada Penderita Hiperetnsi‟, Cermin Dunia Kedokteran, 11 (5): hal 12-20 diakses pada 5 Desember 2012, http://CerminDuniaKedokteran.com/
Faustine, I., 2012. 'Evaluasi Pengaruh Konseling Farmasis Terhadap Hasil Terapi Pasien Hipertensi Usia Lanjut di Poliklinik Jantung RSUD UNDATA Palu Periode November - Desember 2011'. Thesis. Universitas Gadjah Mada, Yogyakarta.
Faujiah, R. dan Lefi, A., 2014. Peran Angiotensin Converting Enzym Inhibitor (ACEI) pada Hipertensi, dalam: Hipertensi Manajemen Komprehensif.
Pusat Penerbitan dan Percetakan Unair (AUP), Surabaya, hal. 203–217.
Fitriani. 2011. Evaluasi Penggunaan Terapi Antihipertensi Terhadap Tekanan Darah Pradialisis Pada Pasien Rawat Jalan Dengan End Stage Renal Disease (ESRD) Yang Menjalani Hemodialisis Rutin Di RS PKU Muhammadiyah Yogyakarta. Jurnal Manajemen dan Pelayanan Farmasi Vol. 1 No. 3 / September 2011
Fung, V., Huang, J., Brand, R., Newhouse, J.P., dan Hsu, J., 2007. Hypertension treatment in a medicare population : adherence and systolic blood pressure control. Clinical Theurapeutics, 29 : 972-984.
Hashmi, S.K, M.B., Abbas, K., Sajwani, R.A., Saleheen D., et al. 2007, Factors Associated with Adherence to Anti-Hypertensive Treatment in Pakistan, New England Journal Medicine, 33 : 280-296.
Heisler, M., Hofer, T.P., Klamerus, M.L., Schmittdiel, J., Selby, J., Hogan, M.M., dkk., 2010. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. Trials, 11: 95.
Hussar, DA., 1995.Patient Compliance, in Remington: The Science and Practise of pharmacy, Philadelphia Collage of Pharmacy and science, USA, 2: hal 1796-1807.
KDOQI, 2007. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease 42: S12–54.
Lee, J.K., Grace, K.A., dan Taylor, A.J., 2006. Effect of Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low- Density Lipoprotein Cholesterol : a randomized controlled trial. JAMA, 296 : 2563-2571.
James PA, Oparil S, Carter BL, dan et al, 2014. 2014 evidence-based guideline for members appointed to the eighth joint national committee (jnc 8). JAMA, 311: 507–520.
Johnson, M., 2004. Prevalence of Comorbid Hypertension and Dyslipidemia and Associated Cardiovascular Disease. Am. J. Manage Care, 10: 926–932.
Kaplan, N. dan Weber, M.A., 2010. Hypertension Essentials 2010. Jones &
Bartlett Learning, Brooklyn, New York.
Matfin, G. dan Porth, C.M., 2011. Disorder of Blood Flow and Blood Pressure, dalam: Essensials of Pathophysiology. Lippincott Williams & Wilkins, hal. 422–438.
Morisky, D., Krousel-Wood, M., dan Ward, H., 2008. Predictive Validity if A Medication Adherence Measure in an Outpatient Setting. J Health-Syst.
Pharm, 10: 48–54.
OBRA, 1990. Omnibus Budget Reconciliation. Act of 1990. Pub. L. No. 101 - 508 and 4401, 104 stat 1388, .
Osterberg, LMD, and Blaschke, TMD, 2005, adherence to Medication, New England Journal Medicine, 353 : 487-497.
Palaian, S., Prabhu, M., dan Shankar, P.R., 2006. Patient Counseling by Pharmacist - A Focus on Chronic Illness. Pak. J. Pharm. Sci., 19 (1): 62–
65.
Permana, T.K., 2014. 'Rasionalitas Penggunaan Obat Antihipertensi dan Outcome Terapi pada Pasien Hipertensi di Poliklinik Penyakit Dalam RSUD Dr.
Moewardi Surakarta', Thesis, Universitas Gadjah Mada.
Pickering, T.G., 1997. The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system.
Journal of Human Hypertension, 11 Suppl 1: S9–18.
Ramadhan, M.A., 2012. 'Pengaruh Ketepatan Terapi dan Kepatuhan Terhadap Hasil terapi Hipertensi di Poliklinik Penyakit Dalam RSUP DR. Sardjito Yogyakarta Periode Februari-April 2012'. Thesis. Universitas Gadjah Mada Yogyakarta.
Saseen, J.J., 2013. Essensial Hypertension, dalam: Applied Therapeutics: The Clinical Use of Drugs, Tenth Editon. Lippincott Williams & Wilkins, New York, 14 : 291–329.
Saseen, J.J. dan Carter, B.L., 2008. Hypertension, dalam: Pharmacotherapy - A Pathophysiologic Approach 8th Edition. McGraw-Hill, New York, hal.
139–169.
Sliwa, K., Stewart, S., dan Gersh, B.J., 2011. Hypertension: a global perspective.
Circulation, 123: 2892–2896.Sja'bani M, 2011, High Dose Fixed Combinaton Therapy of ARB and Diuretics in Severe Hypertension, Universitas Diponegoro, 91-101.
Stephenson, 1999. Noncompliance may cause half of antihypertensive drug
“failures.” JAMA, 282 : 313.
Susalit, E., Kapojos, E.J., dan Lubis, H.R., 2003. Hipertensi Primer, dalam: Buku Ajar Ilmu Penyakit Dalam, Jilid III. Balai Penerbit FKUI, Jakarta, hal.
453–489.
Svarstad, B.L., Kotchen, J.M., Shireman, T.I., Crawford, S.Y., Palmer, P.A., Vivian, E.M., dkk., 2009. The Team Education and Adherence Monitoring (TEAM) Trial: Pharmacy Interventions to Improve Hypertension Control in Blacks. Circulation. Cardiovascular quality and outcomes, 2: 264–271.
Sweetman, 2002. The Complete Drug Reference, 33rd Edition. ed, ISBN 0-85369- 499-0. Pharmaceutical Press, London.
Tambuwun, P.G., Sulung, P.L.,dan Mintjelungan, C.N., 2015, Gambaran Keluhan Di Rongga Mulut Pada Penggunaan Obat Antihipertensi Di Poliklinik Penyakit Dalam Rumah Sakit Tingkat III Robert Wolter Monginsidi. e- GIGI, 3 : 241-245
USP, 1997. USP Medication Counseling Behavior Guidelines. USP Convention, Inc, Rockville MD, 2 : 6-9 .
USPDI, 1997. Advice for Patient. Drug Information in Lay Language, 18th edition. ed. United States Pharmacopoeia, US.
Utari, D. dan Putranto, J.N.., 2014. Terapi Kombinasi pada Hipertensi, dalam:
Hipertensi Manajemen Komprehensif. Surabaya, hal. 292–303.
WHO, 2003. Adherence to Long Term Therapy : Evidence for Action.
Switzerland.
WHO, 2011. The Global Burden of Disease : 2007 update. Geneva : WHO Library Cataloguing in-Publication Data, 40-51.
WHO, 2011. Noncomunicable Disease in The South East Asia Region: Situation and Response 2011. World Health Organization, India.
Williams, G.H., 2000. Penyakit Vaskuler Hipertensif, dalam: Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S., Kasper, D.L., dkk.
(Eds.), Harrison: Prinsip-Prinsip Ilmu Penyakit Dalam. Penerbit Buku Kedokteran EGC, Jakarta, hal. 1256–1272.
Windarti, M.I. dan Ikawati, Z., 2005. 'Tinjauan kesalahan pengobatan Antihipertensi pada pasien hipertensi rawat inap di RS RK Charitas Palembang periode Agustus-Oktober 2004'. Thesis. Universitas Gadjah Mada.
Yogiantoro, M., 2006. Hipertensi Esensial, dalam: Buku Ajar Ilmu Penyakit Dalam, Jilid I, Edisi IV. Pusat Penerbitan Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, Jakarta, hal. 610–614.
